| RXRA |
3T3-L1 (embryonic fibroblasts) |
Day 0 of differentiation |
Permissive
|
Mus musculus |
GSE13511
...
|
MA0065.2
...
|
| RXRA |
3T3-L1 (embryonic fibroblasts) |
Day 1 of differentiation |
Permissive
|
Mus musculus |
GSE13511
...
|
MA0065.2
...
|
| RXRA |
3T3-L1 (embryonic fibroblasts) |
Day 2 of differentiation |
Permissive
|
Mus musculus |
GSE13511
...
|
MA0065.2
...
|
| RXRA |
3T3-L1 (embryonic fibroblasts) |
Day 3 of differentiation |
Permissive
Robust
|
Mus musculus |
GSE13511
...
|
MA0065.2
...
|
| RXRA |
3T3-L1 (embryonic fibroblasts) |
Day 4 of differentiation |
Permissive
Robust
|
Mus musculus |
GSE13511
...
|
MA0065.2
...
|
| RXRA |
3T3-L1 (embryonic fibroblasts) |
Day 6 of differentiation |
Permissive
Robust
|
Mus musculus |
GSE13511
...
|
MA0065.2
...
|
| RXRA |
3T3-L1-derived preadipocytes |
4 hours of differentiation |
Permissive
|
Mus musculus |
GSE27826
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
48hr ethanol |
Permissive
Robust
|
Mus musculus |
GSE30538
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
2hr ATRA |
Permissive
Robust
|
Mus musculus |
GSE30538
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
6hr ATRA |
Permissive
Robust
|
Mus musculus |
GSE30538
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
24hr ATRA |
Permissive
Robust
|
Mus musculus |
GSE30538
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
48hr ATRA |
Permissive
|
Mus musculus |
GSE30538
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
48hr ATRA, RXRa KO |
Permissive
|
Mus musculus |
GSE30538
...
|
MA0065.2
...
|
| RXRA |
NB4 (acute promyelocytic leukemia ) |
24 hours ATRA |
Permissive
|
Homo sapiens |
GSE18886
...
|
MA0065.2
...
|
| RXRA |
UPR9 (hematopoietic stem cells) |
5 hours zinc |
Permissive
Robust
|
Homo sapiens |
GSE18886
...
|
MA0065.2
...
|
| RXRA |
liver |
Bexarotene |
Permissive
Robust
|
Mus musculus |
GSE35262
...
|
MA0065.2
...
|
| RXRA |
liver |
Control |
Permissive
Robust
|
Mus musculus |
GSE35262
...
|
MA0065.2
...
|
| RXRA |
liver |
T0901317 |
Permissive
Robust
|
Mus musculus |
GSE35262
...
|
MA0065.2
...
|
| RXRA |
liver |
Bexarotene |
Permissive
Robust
|
Mus musculus |
GSE35262
...
|
MA0065.2
...
|
| RXRA |
liver |
Control |
Permissive
Robust
|
Mus musculus |
GSE35262
...
|
MA0065.2
...
|
| RXRA |
liver |
T0901317 |
Permissive
Robust
|
Mus musculus |
GSE35262
...
|
MA0065.2
...
|
| RXRA |
liver |
RA-treatment |
Permissive
Robust
|
Mus musculus |
GSE53736
...
|
MA0065.2
...
|
| RXRA |
MC3T3-E1 (preosteoblasts) |
ethanol vehicle |
Permissive
|
Mus musculus |
GSE51513
...
|
MA0065.2
...
|
| RXRA |
MC3T3-E1 (preosteoblasts) |
100nM 1,25(OH)2D3 |
Permissive
|
Mus musculus |
GSE51513
...
|
MA0065.2
...
|
| RXRA |
MC3T3-E1 (preosteoblasts) |
ethanol vehicle |
Permissive
|
Mus musculus |
GSE51513
...
|
MA0065.2
...
|
| RXRA |
MC3T3-E1 (preosteoblasts) |
100nM 1,25(OH)2D3 |
Permissive
|
Mus musculus |
GSE51513
...
|
MA0065.2
...
|
| RXRA |
IDG-SW3 (bone cells) |
100nM 1,25(OH)2D3 for 3 hours |
Permissive
Robust
|
Mus musculus |
GSE54782
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
all-trans retinoic acid 2h |
Permissive
Robust
|
Mus musculus |
GSE56893
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
all-trans retinoic acid 24h |
Permissive
Robust
|
Mus musculus |
GSE56893
...
|
MA0065.2
...
|
| RXRA |
E14TG2A (embryonic stem cells) |
1um Retinoic Acid (RA) for 48hrs |
Permissive
|
Mus musculus |
GSE65695
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
EtOH |
Permissive
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
ATRA 2h |
Permissive
Robust
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
ATRA 6h |
Permissive
Robust
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
ATRA 24h |
Permissive
Robust
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
ATRA 48h |
Permissive
Robust
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
P19 (embryonic carcinoma) |
EtOH |
Permissive
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
P19 (embryonic carcinoma) |
ATRA 2h |
Permissive
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
P19 (embryonic carcinoma) |
ATRA 6h |
Permissive
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
P19 (embryonic carcinoma) |
ATRA 24h |
Permissive
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
P19 (embryonic carcinoma) |
ATRA 48h |
Permissive
Robust
|
Mus musculus |
GSE68540
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived mesenchymal stem cells |
1,25(OH)2D3 |
Permissive
Robust
|
Mus musculus |
GSE79813
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived mesenchymal stem cells |
osteogenic media day 7 |
Permissive
|
Mus musculus |
GSE79813
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived mesenchymal stem cells |
1,25(OH)2D3 + osteogenic media day 7 |
Permissive
|
Mus musculus |
GSE79813
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived mesenchymal stem cells |
osteogenic media day 15 |
Permissive
|
Mus musculus |
GSE79813
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived mesenchymal stem cells |
1,25(OH)2D3 + osteogenic media day 15 |
Permissive
|
Mus musculus |
GSE79813
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived mesenchymal stem cells |
adipose media day 7 |
Permissive
Robust
|
Mus musculus |
GSE79813
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived mesenchymal stem cells |
1,25(OH)2D3 + adipose media day 7 |
Permissive
Robust
|
Mus musculus |
GSE79813
...
|
MA0065.2
...
|
| RXRA |
monocyte-derived macrophages |
untreated |
Permissive
Robust
|
Homo sapiens |
GSE100889
...
|
MA0065.2
...
|
| RXRA |
monocyte-derived macrophages |
IL-4 |
Permissive
|
Homo sapiens |
GSE100889
...
|
MA0065.2
...
|
| RXRA |
embryonic stem cells |
GW3965 for 24 h |
Permissive
|
Mus musculus |
GSE101768
...
|
MA0065.2
...
|
| RXRA |
embryonic stem cells |
LG268 for 24 h |
Permissive
Robust
|
Mus musculus |
GSE101768
...
|
MA0065.2
...
|
| RXRA |
embryonic stem cells |
RA for 24 h |
Permissive
|
Mus musculus |
GSE101768
...
|
MA0065.2
...
|
| RXRA |
liver |
calorie restricted diet |
Permissive
Robust
|
Mus musculus |
GSE47954
...
|
MA0065.2
...
|
| RXRA |
liver |
high-fat diet |
Permissive
Robust
|
Mus musculus |
GSE47954
...
|
MA0065.2
...
|
| RXRA |
liver |
calorie restricted diet |
Permissive
Robust
|
Mus musculus |
GSE47954
...
|
MA0065.2
...
|
| RXRA |
liver |
high-fat diet |
Permissive
Robust
|
Mus musculus |
GSE47954
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived macrophages |
1h IL4 |
Permissive
|
Mus musculus |
GSE107456
...
|
MA0074.1
...
|
| RXRA |
bone marrow-derived macrophages |
STAT6_KO |
Permissive
Robust
|
Mus musculus |
GSE107456
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived macrophages |
PPARG_KO |
Permissive
Robust
|
Mus musculus |
GSE107456
...
|
MA0065.2
...
|
| RXRA |
JMSU-1 (Bladder carcinoma) |
genotype: RXRA WT |
Permissive
Robust
|
Homo sapiens |
GSE107734
...
|
MA0065.2
...
|
| RXRA |
JMSU-1 (Bladder carcinoma) |
genotype: RXRA S427F |
Permissive
Robust
|
Homo sapiens |
GSE107734
...
|
MA0065.2
...
|
| RXRA |
C2C12 (myoblasts) |
50 nM bexarotene for 24 hrs |
Permissive
|
Mus musculus |
GSE94558
...
|
MA0065.2
...
|
| RXRA |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: none; |
Permissive
Robust
|
Homo sapiens |
GSE41561
...
|
MA0065.2
...
|
| RXRA |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BHU
|
MA0512.2
|
| RXRA |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BJD
|
MA0512.2
|
| RXRA |
WA01 (H1, human embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BJW
|
MA0512.2
|
| RXRA |
SK-N-SH (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BVG
|
MA0512.2
|
| RXRA |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR352QSB
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR098XMN
|
MA0065.2
...
|
| RXRA |
NB4 (acute promyelocytic leukemia ) |
|
Permissive
Robust
|
Homo sapiens |
GSE18886
...
|
MA0065.2
...
|
| RXRA |
acute promyelocytic leukemia blasts |
|
Permissive
|
Homo sapiens |
GSE18886
...
|
MA0065.2
...
|
| RXRA |
acute promyelocytic leukemia blasts |
|
Permissive
|
Homo sapiens |
GSE18886
...
|
MA0065.2
...
|
| RXRA |
UPR9 (hematopoietic stem cells) |
|
Permissive
|
Homo sapiens |
GSE18886
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
|
Permissive
Robust
|
Mus musculus |
GSE32332
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
|
Permissive
|
Mus musculus |
GSE32332
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
|
Permissive
Robust
|
Mus musculus |
GSE32332
...
|
MA0065.2
...
|
| RXRA |
C17.2a (neural progenitors) |
|
Permissive
Robust
|
Mus musculus |
GSE38347
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE46762
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE53736
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE21696
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE21696
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE21696
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE21696
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE21696
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE21696
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE21696
...
|
MA0065.2
...
|
| RXRA |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE21696
...
|
MA0065.2
...
|
| RXRA |
IDG-SW3 (bone cells) |
|
Permissive
Robust
|
Mus musculus |
GSE54782
...
|
MA0065.2
...
|
| RXRA |
F9 (embryonal carcinoma) |
|
Permissive
Robust
|
Mus musculus |
GSE56893
...
|
MA0065.2
...
|
| RXRA |
peritoneal macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE63696
...
|
MA0065.2
...
|
| RXRA |
E14TG2A (embryonic stem cells) |
|
Permissive
|
Mus musculus |
GSE65695
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived mesenchymal stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE79813
...
|
MA0065.2
...
|
| RXRA |
embryonic stem cells |
|
Permissive
|
Mus musculus |
GSE101768
...
|
MA1147.1
|
| RXRA |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE101768
...
|
MA0074.1
...
|
| RXRA |
bone marrow-derived macrophages |
|
Permissive
|
Mus musculus |
GSE107456
...
|
MA0494.1
|
| RXRA |
bone marrow-derived macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE107456
...
|
MA0065.2
...
|
| RXRA |
bone marrow-derived macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE107456
...
|
MA0065.2
...
|
| RXRA |
C2C12 (myoblasts) |
|
Permissive
|
Mus musculus |
GSE94558
...
|
MA0065.2
...
|
| RXRA |
|
|
Permissive
|
Homo sapiens |
GSE41561
|
MA0512.2
|
